Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen
- 15 January 2011
- Vol. 29 (10), 1968-1973
- https://doi.org/10.1016/j.vaccine.2010.12.075
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H BindingClinical and Vaccine Immunology, 2010
- Characterization of fHbp , nhba ( gna2132 ), nadA , porA , and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal VaccineClinical and Vaccine Immunology, 2010
- Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolatesVaccine, 2010
- Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humansProceedings of the National Academy of Sciences, 2010
- Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective ActivityClinical and Vaccine Immunology, 2009
- Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from AfricaThe Journal of Infectious Diseases, 2009
- Neisseria meningitidis recruits factor H using protein mimicry of host carbohydratesNature, 2009
- Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2Clinical and Vaccine Immunology, 2009
- Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B VaccineThe Journal of Infectious Diseases, 2007
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006